figshare
Browse
13023_2023_2982_MOESM1_ESM.docx (77.6 kB)

Additional file 1 of Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice

Download (77.6 kB)
journal contribution
posted on 2023-12-03, 04:20 authored by Ine Cockerell, Jakob Christensen, Christina E. Hoei-Hansen, Lotte Holst, Mikkel Grenaa Frederiksen, Aart Imran Issa-Epe, Bård Nedregaard, Ragnar Solhoff, Ketil Heimdal, Cecilie Johannessen Landmark, Caroline Lund, Terje Nærland
Additional file 1: Table S1. Seizure reduction versus no seizure reduction and related factors. Table S2. Seizure reduction (≥/<30 %) and related factors.

Funding

Norwegian National Advisory Unit on Rare Disorders Stiftelsen Kristian Gerhard Jebsen University of Oslo (incl Oslo University Hospital)

History

Usage metrics

    Orphanet Journal of Rare Diseases

    Categories

    Keywords

    Tuberous sclerosis complexmTOR inhibitorEverolimusSirolimusSubependymal giant cell astrocytomaRenal angiomyolipomaEpilepsyAdverse events

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC